-
-
GEMINI Trial; CAMELOT Trial; INVEST Trial; The Dangers of Vitamin E; FDA Actions.
-
Raloxifene treatment of postmenopausal women with osteoporosis is associated with a lower incidence of estrogen receptor-positive invasive breast cancer.
-
This study demonstrates that a sequential screening program that provides patients with first-trimester results and offers the option for early invasive testing or additional serum screening in the second trimester can detect 98% of trisomy 21-affected pregnancies. However, such an approach will result in 17% of patients being considered at risk and, hence, potentially having an invasive test.
-
Abdominal fat increases with advancing age and has been linked to increased risk for diabetes and cardiovascular disease. While insufficient exercise and overeating certainly contribute to age-related acquisition of abdominal fat, hormonal and metabolic factors also have been implicated. Even thin individuals who exercise regularly display increased abdominal fat as they age.
-
-
-
Breast Cancer and the Use of Statins; Warnings Issued for IBS Drugs; FDA Actions.
-
With the muscle of an international cooperative group research network and expanded collaboration, confirmatory trials have been increasingly contemporaneously launched or provided important data in a timely fashion to help solidify important issues in the care of our patients.
-
The use of CEE conferred protection against fracture without an increase in breast cancer but with an increased risk of hypertension, stroke, and venous thromboembolism.
